Page last updated: 2024-08-23

mefloquine and dihydropyridines

mefloquine has been researched along with dihydropyridines in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujita, R; Ishikawa, M; Sasaki, K; Takayanagi, M; Takayanagi, Y	1
Rustenbeck, I; Seemann, N; Welling, A	1

Other Studies

2 other study(ies) available for mefloquine and dihydropyridines

Article	Year
Enhancement of doxorubicin activity in multidrug-resistant cells by mefloquine. Methods and findings in experimental and clinical pharmacology, 2000, Volume: 22, Issue:5 Topics: Affinity Labels; Antibiotics, Antineoplastic; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Binding, Competitive; Calcium Channel Blockers; Coloring Agents; Dihydropyridines; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Mefloquine; Phenotype; Rhodamine 123; Tumor Cells, Cultured; Verapamil	2000
The inhibitor of connexin Cx36 channels, mefloquine, inhibits voltage-dependent Ca Molecular and cellular endocrinology, 2018, 09-05, Volume: 472 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Connexins; Dihydropyridines; Gap Junction delta-2 Protein; Glucose; Insulin Secretion; Insulin-Secreting Cells; Ion Channel Gating; Mefloquine; Mice; Nisoldipine; Potassium Chloride; Tolbutamide	2018

Article

Year

Enhancement of doxorubicin activity in multidrug-resistant cells by mefloquine.

Methods and findings in experimental and clinical pharmacology, 2000, Volume: 22, Issue:5

Topics: Affinity Labels; Antibiotics, Antineoplastic; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Binding, Competitive; Calcium Channel Blockers; Coloring Agents; Dihydropyridines; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Mefloquine; Phenotype; Rhodamine 123; Tumor Cells, Cultured; Verapamil

2000

The inhibitor of connexin Cx36 channels, mefloquine, inhibits voltage-dependent Ca

Molecular and cellular endocrinology, 2018, 09-05, Volume: 472

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Connexins; Dihydropyridines; Gap Junction delta-2 Protein; Glucose; Insulin Secretion; Insulin-Secreting Cells; Ion Channel Gating; Mefloquine; Mice; Nisoldipine; Potassium Chloride; Tolbutamide

2018